Article
Breast cancer metabolism and responsiveness to dichloroacetate: relationships with <sup>15</sup> N and <sup>13</sup> C natural abundance
2026-03-09
Abstract excerpt
<h4>Background</h4> Metabolic reprogramming is a hallmark of breast cancer (BrCa), with alterations in glycolysis, glutamine metabolism, and the urea cycle contributing to tumour progression. Dichloroacetate (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, shifts metabolism toward oxidative phosphorylation and has been proposed as a therapeutic agent. While isotope tracing is well-established, natural isot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9824dac7-defe-5dc5-94e6-9ee67e989f1c
- DOI
- 10.64898/2026.03.09.710495
